课题基金 / 基金详情

Targeting the circadian clock to restore hepatitis B T-cell immunity

Targeting the circadian clock to restore hepatitis B T-cell immunity
针对生物钟恢复乙型肝炎 T 细胞免疫力
批准号:
MR/X020843/1
负责人:
Alan Xiaodong Zhuang
金额:
$192.58万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Circadian rhythms regulate changes in physiological and metabolic processes which allow organisms on earth to respond to daily environmental demands and pathogenic exposure. Host innate and adaptive immune responses are circadian regulated and influence susceptibility to viral infection and response to vaccines. In recent years, scientists have discovered the genetic machinery that underpins the daily cycling of the circadian clock that operates in individual cells. Furthermore, scientists uncovered communications between circadian clocks of different cell types within an organ, and that genetically perturbing the clock in the hepatocytes can impact the clocks in their neighbouring immune cells. Therefore, there is reason to believe that the circadian clock controls immunity within the liver which is essential for viral protection. Hepatitis B virus (HBV) only infects the human liver and remains a major health problem with >270 million chronic infections and 880,000 deaths/year worldwide from liver disease including cirrhosis and cancer. Current antivirals reduce the viral burden but are not curative and do not remove the risk of liver cancer. Chronic hepatitis B is associated with poor anti-viral T-cell immunity that fails to control viral replication. Therefore, curative treatments are desperately needed, and understanding what causes these T-cell defects could aid the design and evaluation of curative therapies.We recently discovered a disruption of clock genes in the liver of HBV patients, which I hypothesise contributes to the poor T-cell response in the infected liver. Importantly, our recent data suggest that manipulation of circadian pathways by drugs can enhance the function of HBV-specific T-cells in CHB patients. Therefore by studying how the circadian system regulates T-cell immunity in the infected liver and how the time of day affects HBV vaccine efficacy, we will identify novel therapeutic opportunities for T-cell restoration and improve the efficacy of HBV therapeutic vaccines. In a broader context, knowledge of the communication of clocks between tissue and local immunity will be applicable to many other pathogens.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ijpharm.2023.123580
发表时间: 2023-11
期刊: International journal of pharmaceutics
影响因子: 5.8
作者: [Zhimin Ma;Xuejuan Zhang;Lu Ping;Zicheng Zhong;Xiubing Zhang;Xiaodong Zhuang;Guanlin Wang;Qiupin Guo;Shaofeng Zhan;Zhenwen Qiu;Ziyu Zhao;Qingguo Li;Dandong Luo]
通讯作者: Zhimin Ma;Xuejuan Zhang;Lu Ping;Zicheng Zhong;Xiubing Zhang;Xiaodong Zhuang;Guanlin Wang;Qiupin Guo;Shaofeng Zhan;Zhenwen Qiu;Ziyu Zhao;Qingguo Li;Dandong Luo
DOI: 10.1016/j.isci.2023.108763
发表时间: 2024-01-19
期刊: ISCIENCE
影响因子: 5.8
作者: [Zhuang, Xiaodong, Gallo, Giulia, Sharma, Parul, Ha, Jiyeon, Magri, Andrea, Borrmann, Helene, Harris, James M., Tsukuda, Senko, Bentley, Eleanor, Kirby, Adam, de Neck, Simon, Yang, Hongbing, Balfe, Peter, Wing, Peter A. C., Matthews, David, Harris, Adrian L., Kipar, Anja, Stewart, James P., Bailey, Dalan, McKeating, Jane A.]
通讯作者: McKeating, Jane A.
国内基金
海外基金
基于生命节律的数字化口服给药系统及方法的研究
  • 批准号:
    30700160
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    16.0万元
  • 批准年份:
    2007
  • 负责人:
    皮喜田
  • 依托单位: